ArticleThe oncologist2022

Regarding "Management of Dermatologic Events Associated with the Nectin-4-directed Antibody-Drug Conjugate Enfortumab Vedotin".

Saskia Ingen-Housz-Oro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.